Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Hong

Showing results (381-390 of 384) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 384 results.
Hypertension (Dallas, Tex. : 1979)|April 1, 2022
Associations of Long-Term Visit-to-Visit Blood Pressure Variability With Subclinical Kidney Damage and Albuminuria in Adulthood: a 30-Year Prospective Cohort StudyYang Wang, Peng Zhao, Chao Chu, et al.
Nature Communications|January 20, 2019
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogrammingLei Xiong, Feng Wu, Qiong Wu, et al.
Journal of Hematology & Oncology|December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myelomaWan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 39

Showing results (381-390 of 384) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 384 results.
Hypertension (Dallas, Tex. : 1979)|April 1, 2022
Associations of Long-Term Visit-to-Visit Blood Pressure Variability With Subclinical Kidney Damage and Albuminuria in Adulthood: a 30-Year Prospective Cohort StudyYang Wang, Peng Zhao, Chao Chu, et al.
Nature Communications|January 20, 2019
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogrammingLei Xiong, Feng Wu, Qiong Wu, et al.
Journal of Hematology & Oncology|December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myelomaWan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 39